"Six-Year Rule" On Access To PMA Data Applies To All PMAs Since 1990
This article was originally published in The Gray Sheet
Executive Summary
FDA's decision to apply the FDA Modernization Act's "six-year rule" to premarket approval applications approved prior to enactment of the statute is consistent with a "least burdensome" approach, the agency maintains.
You may also be interested in...
Cook Suggests Six-Year Rule Supporting PTCA Catheter Downclassification
FDAMA's "six-year" rule allows FDA to support the downclassification of PTCA balloon catheters with information from approved PMAs, the MED Institute, a unit of The Cook Group, suggests.
Cook Suggests Six-Year Rule Supporting PTCA Catheter Downclassification
FDAMA's "six-year" rule allows FDA to support the downclassification of PTCA balloon catheters with information from approved PMAs, the MED Institute, a unit of The Cook Group, suggests.
FDA's Retroactive Use Of PMA Data Violates FDAMA, HIMA Petition Says
FDA violated the FDA Modernization Act by applying retroactively a provision of the law relating to use of data from approved premarket approval applications, the Health Industry Manufacturers Association maintains in an Aug. 9 citizen petition.